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Much of the mutualistic relationship between humans and their resident intestinal Bacteroides species is
founded on glycans. The host provides plant polysaccharides and host-derived glycans and, in return,
receives beneficial end products of bacterial fermentation. Glycans from the bacteria themselves are
required for the establishment and survival of these organisms in the colonic ecosystem and provide immu-
nomodulatory properties to the host. Coordinated synthesis and catabolism of bacterial glycans is likely to
contribute to the host-bacterial mutualism.The Human Intestinal Ecosystem
The human digestive tract is specifically designed to obtain nutri-
ents from ingested food, with compartmentalized regions per-
forming distinct yet concerted functions. Digestion begins in
the mouth with the breakdown of starch by amylase in the saliva.
As the food passes to the stomach, acid is released, along with
enzymes that aid in protein degradation. The chyme that enters
the small intestine is mixed with bile to emulsify lipids for break-
down and absorption. The small intestine is also the region
where macromolecules are broken down to smaller components
with subsequent absorption of vitamins, small protein fragments,
monosaccharides, and degraded lipids. The material that enters
the large intestine (colon) is relatively devoid of dietary proteins,
lipids, and simple sugars. Although starch is mostly degraded in
the small intestine, some may also transit to the colon. The
majority of the undigested macromolecules that arrive in the
colon are complex nonstarch polysaccharides (dietary fiber)
that the host does not have the enzymatic capability to degrade.
Digestion in the colon is greatly aided by the trillions of microbes
that inhabit this niche. This consortium of microorganisms
produces an enormous enzymatic repertoire with the capacity
to break down an extensive array of complex polysaccharides
that the host is unable to process. In this regard, the intestinal mi-
crobiota has been referred to as a metabolic organ (Martens
et al., 2008).
The numerically abundant microbial species of the human
colonic ecosystem have evolved features that allow them to
dominate this niche. Like the food’s journey through the diges-
tive chambers, the microbes that inhabit the colon are acquired
orally and therefore are exposed to the harsh conditions of the
digestive system en route to their niche. Organisms that
successfully reach the colon must have survived the low pH of
the stomach, the bile that is secreted into the small intestine,
and intestinal innate immune factors designed to kill ingested
microbes. Once in the colon, the abundant commensal microbes
must establish themselves in a manner that does not deleteri-
ously affect the host. In this regard, most resident colonic
bacteria do not intimately interact with the intestinal epithelial
cells but rather remain on the outer mucus layer overlying the
epithelial surface (Johansson et al., 2008). In addition, the abun-
dant Gram-negative bacteria of this ecosystem typically lack522 Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc.some of the molecules that stimulate innate host immunity,
such as a potent endotoxin and enteric type flagella. To establish
long-term colonization of this niche, these bacteria must have
mechanisms to defend against attacks from other microbial
members of the ecosystem and from phage. Of utmost impor-
tance for survival is that the bacteria are able to utilize the nutri-
ents that are available in the ecosystem and do so in a manner
that is efficient, sufficiently diverse, and responsive to nutritional
changes.
An individual’s intestinal microbiota is comprised of hundreds
of different species of bacteria; however, there are relatively
few that predominate. In general, bacteria from two phyla
comprise the numerical majority: the Gram-positive Firmicutes
and the Gram-negative Bacteroidetes (Eckburg et al., 2005).
Within the Bacteroidetes phylum, the human gut organisms fall
within the order Bacteroidales with two predominant genera,
the Bacteroides and the Parabacteroides. Bacteroides species
are among the most studied of the abundant gut bacteria, and
much of their ability to thrive in this ecosystem directly pertains
to their use and production of glycans. Host, dietary, and bacte-
rial glycans play essential roles in the mutually beneficial (mutual-
istic) host-Bacteroides relationship. Bacteroides species have
extensive machinery to utilize the complex polysaccharides
present in the colon as a source of carbon and energy. In doing
so, they produce fermentative end products in the form of
short-chain fatty acids (SCFAs) that provide nutrition and other
beneficial properties to the host. The production of several
different types of glycans by the Bacteroides also aids the mutu-
alism, as their production is essential for bacterial survival and
provides beneficial immunomodulatory properties to the host.
The Bacteroides’ Extensive Glycan
Utilization Machinery
The polysaccharide composition of the colonic ecosystem is
comprised not only of the complex plant polysaccharides, which
the host lacks the enzymatic capacity to degrade, but also of
host-derived mucopolysaccharides contained in the mucus
layer overlaying the intestinal epithelial surface. The glycoprotein
mucins are diverse in both their monosaccharide composition
and glycan linkages. Both dietary and host glycans provide a
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MinireviewFigure 1. Overview of the Glycan Utilization and Synthesis Pathways in Bacteroides fragilis
Glycan fermentation and synthesis are a foundation for the bacteria’s mutualistic relationship with the host. The upper left of the bacterial cell shows products
encoded by a model PUL. The dietary or host glycan first binds to a glycan-specific SusD-like outer surface lipoprotein. In some cases, outer surface glycohy-
drolases can begin to degrade the polymer to smaller oligosaccharides that are then transported into the periplasm by the outer membrane TonB-dependent
b-barrel SusC-like proteins. In the periplasm, additional glycohydrolases degrade the molecule to monosaccharide components that are transported to the cyto-
plasm by sugar-specific permeases. B. fragilis and other Bacteroides species do not have phosphotransfer sugar transport systems (Brigham and Malamy,
2005), and monosaccharides are therefore imported into the cytoplasm uncharged. At this point, the monosaccharides can either be destined for incorporation
into bacterial glycans or for catabolism. The B. fragilis genome encodes at least two enzymes that can directly convert unphosphorylated monosaccharides
(fucose and sialic acid) into their nucleotide-activated forms for incorporation into bacterial glycans. Three of the glycan types synthesized byB. fragilis are shown.
The EPS is a large polymer that extends far from the bacterial surface. The capsular polysaccharides are more closely associated with the cell surface, but they
can be released either by sloughing or in the form of outer membrane vesicles (Patrick et al., 1996), where they provide immunomodulatory properties to the host.
The glycoproteins are essential for the bacteria’s normal functioning and localize to the outer surface, outer membrane, and periplasm. Alternative to use in glycan
synthesis, the uncharged monosaccharide can be acted upon by different enzymes. The cytoplasmic hexokinases, RokA and HexA, collectively phosphorylate
most hexoses and N-acetylated hexoses on the sixth carbon. At this point, the hexose-6-P can serve as a substrate for catabolism or as a substrate for phos-
phohexomutases. These proteins catalyze the reversible synthesis of hexose-1-P, which are the substrates for nucleotidyltransferases that convert these sugars
to their nucleotide-activated forms. These simple nucleotide-activated hexoses then serve as substrates for the synthesis of more complex nucleotide-activated
di- and trideoxysugars that are incorporated into bacterial glycans. Alternatively, the catabolism of these monosaccharides provides SCFAs that benefit the host.rich nutrient source for those colonic organisms that are equip-
ped with the enzymatic arsenal to harvest them.
Early studies of Bacteroides thetaiotaomicron demonstrated
its ability to utilize a variety of plant and host polysaccharides
for its metabolism (reviewed in Salyers, 1990), but not until the
publication of the first Bacteroides genome sequence was the
extent of this capacity appreciated (Xu et al., 2003). The B. the-
taiotaomicron VPI-5482 genome contains 88 polysaccharide
utilization loci (PULs) (Martens et al., 2008), each of which
encodes sets of proteins involved in sensing, importing, and de-
grading specific glycans of the colonic ecosystem. The first char-
acterized PUL of B. thetaiotaomicron was the sus locus involved
in starch utilization, which is comprised of eight genes encoding
SusR and SusA–SusG. The Sus products include a regulatory
protein; five outer membrane proteins involved in starch binding,
degradation, and import into the periplasm (Reeves et al., 1996);
and two periplasmic glycohydrolases with neopullulanase and
a-glucosidase activity (D’Elia and Salyers, 1996).Although different PULs encode different repertoires of func-
tional products involved in the utilization of specific polysaccha-
rides, there are many commonalities between these loci. PULs
often contain genes encoding hybrid two-component histidine
kinase response regulators, ECF-type sigma factors and anti-
sigma factors, outer membrane proteins involved in nutrient
binding and import (SusD and SusC paralogs, respectively),
and glycohydrolases that enzymatically cleave the glycosidic
linkages of specific glycans (Martens et al., 2008). Transcrip-
tional profiling of bacteria grown on media containing single
polysaccharides is allowing assignments of specific glycans
utilized by specific PULs. The cellular localizations of representa-
tives of some of the products encoded by PULs are shown in
Figure 1.
The genome sequences of other abundant human gut Bacter-
oides species demonstrate similar expansions of PULs, although
there are some differences in the metabolic capacities of
different species. For example, B. thetaiotaomicron VPI-8254Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc. 523
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chondroitin, and hyaluronan, whereas other Bacteroides species
lack the necessary enzymatic arsenal to harvest these molecules
(Xu et al., 2007). Other Bacteroides species, however, have
glycolytic capabilities absent in B. thetaiotaomicron, such as B.
vulgatus’s large complement of enzymes that target pectin (Xu
et al., 2007). Because humans are colonized with many different
Bacteroides species simultaneously, the composite polysaccha-
ride degradative abilities of the collective Bacteroides population
within an individual are enormous.
Several studies of B. thetaiotaomicron show that this
organism has evolved mechanisms to prioritize glycan usage
depending on nutrient availability within the ecosystem. Anal-
yses using gnotobiotic mice supplied with diets either devoid
of or rich in dietary polysaccharides have revealed a preference
for utilization of dietary polysaccharides over host-derived
glycans (Sonnenburg et al., 2005). If dietary polysaccharides
are scarce, there is an increase in the expression of PULs
involved in utilizing host glycans (Sonnenburg et al., 2005). In
the absence of dietary glycans, the types of host glycans that
are utilized are further prioritized. When three of the prominent
host glycans of the intestine are each provided to B. thetaiotao-
micron in vitro, the organism preferentially uses glucosaminogly-
cans over mucin O-glycans and N-glycans (Martens et al.,
2008). However, bacteria isolated from gnotobiotic mice mono-
associated with B. thetaiotaomicron demonstrate that the PULs
for glucosaminoglycans are not highly expressed compared to
those involved in O-glycan utilization, and therefore glucosami-
noglycans may not be a readily available nutrient source in the
mouse cecum.
The question arises as to whether the intestinal Bacteroides
are selfish with regard to their nutrient utilization or whether
they share their degradative products with microbial members
less adapted to utilize the available complex glycan pool,
possibly forming symbiotic or mutualistic microbial relation-
ships. The data suggest that although some glycohydrolases
are present on the bacterial surface, the polysaccharide
substrate is likely anchored to the outer membrane first via
a SusD paralog and is subsequently transported into the peri-
plasm for further degradation. It is unlikely that these bacteria
release a large number of soluble extracellular glycohydrolases,
and therefore they probably do not extensively share with their
microbial neighbors nor harvest glycans that are not first associ-
ated with the bacterial surface.
The degradation of dietary polysaccharides by the Bacter-
oides does, however, contribute significantly to host nutrition.
End products of fermentation of these complex polysaccharides
include SCFAs that are excreted to the intestinal lumen and
utilized by host cells as a source of energy (Bergman, 1990).
Therefore, the utilization of dietary glycans by these resident
bacteria is the basis of a nutritional mutualism between host
and microbe. In addition, SCFAs are reported to be essential
to the overall health of the colon and one in particular, butyrate,
has been demonstrated to have anticancer properties (reviewed
in Hamer et al., 2008), leading to the prediction by many that the
production of butyrate by the intestinal microbiota as an end
product of dietary polysaccharide fermentation may be the link
between a high-fiber diet and the decreased incidence of colon
cancer.524 Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc.Extensive Glycan Synthesis by the Intestinal
Bacteroides
The great expansion of loci involved in glycan utilization by the
Bacteroides is mirrored by an expansion of loci involved in bacte-
rial glycan synthesis. The intestinal Bacteroidales dedicate
a large amount of their genetic material to the synthesis of glyco-
sylated molecules. A single strain of Bacteroides fragilis, for
example, synthesizes eight distinct capsular polysaccharides
(Krinos et al., 2001), an extracellular polysaccharide (Chatzi-
daki-Livanis et al., 2008), and a large number of glycoproteins
(Fletcher et al., 2009). The B. fragilis 9343 genome encodes
80 predicted glycosyltransferases and dedicates approxi-
mately 215,000 kb of its genome to the synthesis and regulation
of glycans (Coyne et al., 2008).
The expression of each of the eight capsular polysaccharides
of B. fragilis is subject to phase variation dictated by DNA inver-
sions of the promoter regions upstream of seven of the eight
polysaccharide biosynthesis loci (Krinos et al., 2001), conferring
great antigenic variability to these organisms. The synthesis of
multiple phase-variable capsular polysaccharides is a conserved
feature of the intestinal Bacteroidales species, but not of the
closely related oral species of this order, suggesting that this
property confers an advantage for intestinal survival. The biolog-
ical significance of the synthesis of such a large repertoire of
phase-variable capsular polysaccharides by these bacteria is
not yet fully understood. Production of at least one capsular
polysaccharide is absolutely essential for B. fragilis to competi-
tively colonize the gnotobiotic mouse intestine; however, an
acapsular mutant is able to colonize to the same density as
wild-type bacteria in the absence of competition (Coyne et al.,
2008). Although the acapsular bacteria are equally as resistant
as the wild-type to conditions of low pH and to bile (Coyne
et al., 2008), the acapsular bacteria may be less fit to survive
transit through the upper digestive tract, possibly due to greater
sensitivity to innate immune factors. Selective killing of the acap-
sular bacteria in the upper digestive tract would result in lower
numbers to competitively colonize the colon. Unlike the acapsu-
lar mutant, a B. fragilis mutant able to express only a single
capsular polysaccharide competitively colonizes the colon of
gnotobiotic mice (Coyne et al., 2008).
The synthesis of multiple phase-variable capsular polysaccha-
rides is likely essential for the long-term colonization of these
species in the normally complex human colonic microbiota.
Capsular polysaccharides are often the targets of deleterious
products of the colonic ecosystem such as phage adhesins and
phage glycohydrolases. The ability of these bacteria to express
subpopulations of organisms expressing distinct capsular poly-
saccharide surfaces would ensure that there is always a popula-
tion of bacteria able to withstand an assault. The eight capsular
polysaccharide biosynthesis loci are heterogenous within the
species, meaning that differentB. fragilis strains express compo-
sitionally and structurally distinct capsular polysaccharides.
Therefore, it is unlikely that each capsular polysaccharide has
a distinct function, per se; rather, the conserved and selected
feature is the ability to express a large and varied repertoire of
distinct surface polysaccharide structures.
In addition to the benefit afforded the bacteria by their ability to
successfully colonize their niche, the capsular polysaccharides
of B. fragilis also provide a beneficial property to the host. One
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9343, PSA, is an immunomodulatory molecule that has been
demonstrated to prevent the development of colitis in an exper-
imental animal model (Mazmanian et al., 2008). The immuno-
modulatory properties of this molecule lie in its zwitterionic
nature, having both positive and negative charges on each
repeat unit of the polymer. Although there is great variability in
the PSA molecules synthesized by distinct B. fragilis strains,
the last two genes of the PSA biosynthesis locus are conserved
in the species and are involved in the synthesis and addition of
the positively charged monosaccharide of PSA. Analysis of the
genome sequences of numerous Bacteroides species reveals
that many of the polysaccharide biosynthesis loci contain
genes encoding both amino transferases and dehydrogenases
(M. Coyne and L.C., unpublished data), which confer positive
and negative charges to polysaccharides, respectively. There-
fore, the production of immunomodulatory zwitterionic polysac-
charides may be a common property of intestinal Bacteroides
species.
The glycan synthesis machinery of B. fragilis also extends to
glycoproteins and an exopolysaccharide (EPS). As yet, the func-
tional significance of the phase-variable EPS has not been eluci-
dated, and its importance may be confined to specific in vivo
conditions. The glycoproteins, however, are critically important
not only for in vivo survival of the bacteria, but also for the normal
functioning of the organism.B. fragilis and other human intestinal
Bacteroides species are some of the few bacteria demonstrated
to have a general protein glycosylation system and the first
O-glycosylation system shown to use a defined glycosylation
motif (Fletcher et al., 2009). Although the number of proteins
glycosylated in B. fragilis is unknown, it is likely extensive and
includes molecules that localize to the periplasm, outer
membrane, and cell surface. Many of these molecules are pre-
dicted to have roles in fundamental processes of the organism,
including protein folding, protein-protein interactions, and
protein degradation. It is not yet known if the glycoproteins of
Bacteroides species are ‘‘symbiotic’’ molecules that provide
beneficial properties to the host. Construction of defined
mutants not only of general glycosylation functions but also of
individual glycoproteins will aid in determining the contribution
of these molecules to human health.
The plethora of polysaccharides and glycans that these bacte-
rial species supply to the intestinal milieu raises the question of
whether bacterial species can catabolize their own glycans or
those of other microbial members. The types of monosaccha-
rides that are components of bacterial glycans in general are
extremely diverse compared to the relatively few monosaccha-
rides that comprise eukaryotic glycans. Bacteroides species in
particular synthesize many complex di- and trideoxy sugars
that are incorporated into their capsular polysaccharides (Coyne
et al., 2008). Production of complex polysaccharide structures
by intestinal Bacteroides may have evolved because the
complex polysaccharides are likely resistant to the large arsenal
of bacterial glycohydrolases these bacteria produce. Although it
is unlikely that most of the complex Bacteroides glycans are
utilized as a nutrient source by the resident bacteria, this may
not be true of all bacterial polysaccharides of this ecosystem.
A recent study has shown that Gram-positive Bifidobacterium
strains of the human colonic ecosystem produce EPSs that arefermentable substrates for various intestinal bacteria (Salazar
et al., 2008). Therefore, glycan-mediated symbioses may also
occur between microbial members of the human intestinal
ecosystem.
Catabolism versus Glycan Synthesis
The fact that Bacteroides species can collectively reach densi-
ties of greater than 1010 bacteria per gram of human colonic
contents necessitates an extreme demand for the harvest of
carbon from the ecosystem and the concomitant production of
energy. The carbon demand is further augmented as it is
required for the synthesis of the numerous glycosylated mole-
cules that are essential to the survival of these bacteria in their
ecosystem. The degradation of host and dietary glycans by the
numerous PULs of Bacteroides species results in the release
of single monosaccharide components in the periplasmic space.
The transport of these monosaccharides to the cytoplasm
involves sugar-specific permeases that import monosaccha-
rides without the simultaneous phosphorylation (Brigham and
Malamy, 2005) that occurs in many other bacteria. The majority
of these monosaccharides are then converted to their hexose-
6-P forms via the action of two cytoplasmic sugar kinases—
RokA and HexA—that collectively phosphorylate a broad range
of hexoses and N-acetylated hexoses (Brigham and Malamy,
2005). Many of the hexose-6-P molecules can then be directed
into either of two pathways, one for the synthesis of bacterial
glycans and the other for catabolism (Figure 1).
At least two monosaccharides, fucose and sialic acid, have
alternative pathways for both catabolism and incorporation into
bacterial glycans. B. fragilis synthesizes two different enzymes,
Fkp (Coyne et al., 2005) and a putative CMP-sialic acid synthe-
tase (BF3831), which allow for the direct nucleotide activation
of each of these monosaccharides, respectively, directing them
for glycan synthesis. fkp is present in the genomes of all intestinal
Bacteroidales species analyzed; however, it is rarely present in
the genomes of other bacteria. The conservation of this gene in
the intestinal Bacteroidales may be due to a large fucose require-
ment by these species, as this monosaccharide is a component
of both capsular polysaccharides and glycoproteins. An alterna-
tive fate for the cytoplasmic fucose and sialic acid is that they can
be utilized for catabolism. Whether these molecules are used for
glycan synthesis or catabolized likely depends on the amounts of
competing enzymes for these pathways. The intestinal Bacteroi-
dales species Parabacteroides distasonis, which produces
a tremendously large number of fucosylated glycans compared
toBacteroides species (Coyne et al., 2005), lacks a fucose utiliza-
tion system (Xu et al., 2007). Therefore, in this organism, all the
acquired fucose from the ecosystem can be shunted to the
glycan synthesis pathway via Fkp.
Conclusions
Much of the mutualistic relationship that exists between humans
and their resident intestinal Bacteroides species is founded on
a glycan-based interplay between these organisms. The host
provides the Bacteroides with nutrients in the form of plant poly-
saccharides and host-derived glycans that these microbes are
exquisitely adept at sensing and utilizing accordingly. In return,
the host receives the augmented metabolic capacity contributed
by the Bacteroides and the beneficial end products of bacterialCell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc. 525
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mutualism, as they are required for the establishment and
survival of these organisms in the colonic ecosystem and also
provide important immunomodulatory properties to the host.
There is still much work to be done defining which polysaccha-
rides are utilized by each of the PULs of Bacteroides species.
Although there are likely many overlapping glycan utilization
profiles between different Bacteroides species, the data are
also revealing that there may be species-specific PULs, which
may help explain why different Bacteroides species coexist
within an individual’s colonic microbiota. Studies of glycan
synthesis by the intestinal Bacteroides have mainly been
directed at genetic and enzymatic analysis of biosynthesis and
regulation, and few studies have analyzed the synthesis of these
bacterial polysaccharides in vivo. There are many open ques-
tions regarding the interplay between glycan hydrolysis and
glycan synthesis and whether glycan availability impacts the
synthesis of specific polysaccharides. It will be interesting to
determine if the orientations of the invertible capsular polysac-
charide promoters are influenced by differing environmental
conditions, especially the availability of specific nutrients in the
ecosystem. Such analyses may demonstrate a correlation
between the sensing and utilization of a specific polysaccharide
from the ecosystem and the concomitant alteration of the bacte-
ria’s polysaccharide surface.
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